Fully Agree that a buyout would yield far less in the long run!! I also would like to pose a question to any Bio-Chem people on here....First a multiple antibody target approach to attacking cancer cells and second hooking up the antibody to a far more cytotoxic agent(thinking long poisonous organic compounds)? I think the latter of the two might be difficult....still retains toxicity even tho linked or broken down before it can reach tumor...also possible indigenous antibodies recognize long compound?? Just thinking out loud any thoughts??